February 2, 2010
 

Recalls and Safety Alerts: Caution on Powerheart and CardioVive Automated External Defibrillators


Recalls and Safety Alerts: Caution on Powerheart and CardioVive Automated External Defibrillators
FDA is alerting users of certain Powerheart and CardioVive automated external defibrillators that these devices may malfunction unexpectedly. This can cause a failure to deliver the electric shocks that are needed to treat sudden cardiac arrest or a...
Source: www.accessdata.fda.gov

Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
Patients with moderate or severe hepatic impairment should be treated with reduced starting doses and closely monitored.
Source: www.fda.gov

Nzu, Traditional Remedy for Morning Sickness
Consumers, especially pregnant or breastfeeding women, advised to avoid product because of the potential health risks from high levels of lead and arsenic
Source: www.fda.gov

Tylenol Arthritis Pain Caplet, 100 count bottles: Recall of all lots
[UPDATE 01/15/2010] Recall expanded from December 2009 due to reports of moldy, musty, or mildew-like odor that was associated with nausea, stomach pain, vomiting and diarrhea. Posted 12/28/2009
Source: www.fda.gov

ev3 Endovascular Inc. Trailblazer Support Catheter: Class I Recall
Device may crack near the radiopaque marker band, potentially resulting in serious patient injury.
Source: www.fda.gov

Videx/Videx EC (didanosine): Labeling Revision - Risk of Non-Cirrhotic Portal Hypertension
Risk information added to Warnings/Precautions section and data summary provided
Source: www.fda.gov

Subscribe to Posts [Atom]